G-rich DNA suppresses systemic lupus

Journal of the American Society of Nephrology

Volumn 16, Issue 11, 2005, Pages 3273-3280

  Patole, Prashant S ^a   Zecher, Daniel ^a   Pawar, Rahul D ^a   Gröne, Hermann Josef ^b   Schlöndorff, Detlef ^a   Anders, Hans Joachim ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA; OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9; CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; ENDOSOME; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; KIDNEY CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL LINE; DNA METHYLATION; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL LINE; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; MACROPHAGES; MICE; MICE, MUTANT STRAINS; OLIGODEOXYRIBONUCLEOTIDES;

EID: 33144458473     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005060658     Document Type: Article

References (31)

1. Klinman DM: Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4: 249-258, 2004
2. Ulevitch RJ: Therapeutics targeting the innate immune system. Nat Rev Immunol 4: 512-520, 2004
3. Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R, Aguzzi A: Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10: 187-192, 2004
4. Anders HJ, Banas B, Linde Y, Weller L, Cohen CD, Kretzler M, Martin S, Vielhauer V, Schlondorff D, Grone HJ: Bacterial CpG-DNA aggravates immune complex glomerulonephritis: Role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol 14: 317-326, 2003
5. Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fujinami RS: Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 9: 481-493, 1999
6. Miyata M, Kobayashi H, Sasajima T, Sato Y, Kasukawa R: Unmethylated oligo-DNA containing CpG motifs aggravates collagen-induced arthritis in mice. Arthritis Rheum 43: 2578-2582, 2000
7. Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Grone HJ, Schlondorff D: Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 18: 534-536, 2004
8. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607, 2002
9. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD: Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115: 407-417, 2005
10. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549, 1995
11. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321: 209-213, 1986
12. Ishii KJ, Gursel I, Gursel M, Klinman DM: Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. Curr Opin Mol Ther 6: 166-174, 2004
13. Richardson B: DNA methylation and autoimmune disease. Clin Immunol 109: 72-79, 2003
14. Stacey KJ, Young GR, Clark F, Sester DP, Roberts TL, Naik S, Sweet MJ, Hume DA: The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 170: 3614-3620, 2003
15. Stunz LL, Lenert P, Peckham D, Yi AK, Haxhinasto S, Chang M, Krieg AM, Ashman RF: Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32: 1212-1222, 2002
16. Lenert P, Stunz L, Yi AK, Krieg AM, Ashman RF: CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation. Antisense Nucleic Acid Drug Dev 11: 247-256, 2001
17. Zeuner RA, Verthelyi D, Gursel M, Ishii KJ, Klinman DM: Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis. Arthritis Rheum 48: 1701-1707, 2003
18. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE: Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 25: 689-695, 1984
19. de Jong JP, Leenen PJ, Voerman JS, van der Sluijs-Gelling AJ, Ploemacher RE: A monoclonal antibody (ER-HR3) against murine macrophages. IL Biochemical and functional aspects of the ER-HR3 antigen. Cell Tissue Res 275: 577-585, 1994
20. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, Conrad C, Ittner LM, Bauer S, Luther SA, Uematsu S, Akira S, Hengartner H, Zinkernagel RM: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11: 138-145, 2005
21. Crow MK, Kirou KA: Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol 16: 541-547, 2004
22. Huck S, Deveaud E, Namane A, Zouali M: Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis. FASEB J 13: 1415-1422, 1999
23. Vinuesa CG, Goodnow CC: Immunology: DNA drives autoimmunity. Nature 416: 595-598, 2002
24. Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A: Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204: 27-42, 2005
25. Wagner H: The immunobiology of the TLR9 subfamily. Trends Immunol 25: 381-386, 2004
26. Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S: Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 34: 2541-2550, 2004
27. Kerkmann M, Costa LT, Richter C, Rothenfusser S, Battiany J, Hornung V, Johnson J, Englert S, Ketterer T, Heckl W, Thalhammer S, Endres S, Hartmann G: Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. J Biol Chem 280: 8086-8093, 2005
28. Ronnblom L, Aim GV: An etiopathogenic role for the type IIFN system in SLE. Trends Immunol 22: 427-431, 2001
29. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L: Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50: 1861-1982, 2004
30. Yamada H, Ishii KJ, Klinman DM: Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung. Crit Care Med 32: 2045-2049, 2004
31. Petri M: Hydroxychloroquine: Past, present, future. Lupus 7: 65-67, 1998